Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
Become a Member | Sign in
Home>Events>This Event
  Events - July 2014

ON Helix

02 Jul 2014 - 02 Jul 2014 - Cambridge, UK

Bookmark and Share

The ‘ON Helix’ translational research conference will bring together key experts from industry and academia to discuss how we can help ground-breaking primary research successfully transition into treatments for patients.

The topics covered during this one day event will centre around:

  • The UK business environment 
  • Research funding
  • Scientific and clinical research excellence 
  • How ideas and early stage inventions are turned into innovative health treatments 

The high profile global leaders that will give presentations and/or join in as part of panel discussions include:

  • Dr. Mene Pangalos, Executive Vice president Innovative Medicines and Early Research at AstraZeneca
  • Sir Mike Rawlins, Chairman of the EAHSN and President of the Royal Society of Medicine
  • Sir Gregory Winter, Master, Trinity College, Cambridge and founder of Bicycle Therapeutics Ltd
  • Rob Pinnock, Director Scientific Liaison, UK, Ireland, Portugal and Spain, Merck Sharp & Dohme 
  • Hermann Hauser, serial Cambridge entrepreneur and venture capitalist 
  • and other highly regarded and respected personalities form industry and academia

 This event is aimed at:

  • Biotech and healthcare company, senior executives
  • Academic technology transfer executives
  • Pharma business and research development directors
  • Life science investors
  • Technical and professional service providers

At the end of the talk and panel discussions, there will be a drinks reception and plenty of time for networking and partnering.

Further information
Scientific News
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
Less Frequent Cervical Cancer Screening
HPV-vaccinated women may only need one screening every 5 to 10 years with screening starting later in life.
Targeting Cannabinoid CB2 Receptors in the CNS
With endogenous cannabinoids considered as a potential target to combat CNS diseases, this article examines the role of CB2R could play in fighting some disorders.
Bacterial Genes Boost Current in Human Cells
Borrowing and tweaking bacterial genes to enhance electrical activity might treat heart, nervous system injury.
Cocoa Compound Linked to Some Cardiovascular Biomarker Improvements
The study highlights the urgent need for large, long-term RCTs that improve understanding of how the short-term benefits of cocoa flavanol intake on cardiometabolic biomarkers may be translated into clinical outcomes.
Untangling a Cause of Memory Loss in Neurodegenerative Diseases
The mouse study identifies a possible therapeutic target for a family of disorders.
New Pathway for COPD Biomarker Development
A study from Philip Morris International has highlighted multi-lipid profiling as a potential new pathway for COPD biomarker development.
Stiffening a Blow to Cancer Cells
Researchers develop a way to predict how a tumor tissue's physical properties affect its response to chemotherapy drugs.
Anti-Cancer Drug Uses Tumour mRNA to Identify Responders
Phase I study of novel anti-cancer drug uses tumour mRNA expression to identify patients who will respond to the drug.
New Strategy for Choosing Cancer Drugs
Device can predict tumor responses by measuring cell growth after drug exposure.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,100+ scientific videos